Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
436 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06607627 | PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis | recruiting | Phase 3 | 12 | Alexion Pharmaceuticals, Inc.INDUSTRY | 5 | Apr 1, 2026 | clinicaltrials |
| NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera(GIV-IN-PV) | recruiting | Phase 3 | 220 | ItalfarmacoINDUSTRY | 16 | Mar 25, 2026 |
| NCT06793072 | Adipokines in Polycystic Ovary Syndrome | recruiting | — | 300 | Jagiellonian UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06793085 | Pro- and Anti-inflammatory Cytokines in PCOS | recruiting | — | 100 | Jagiellonian UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06793098 | Functional Proteins in Polycystic Ovary Syndrome | recruiting | — | 100 | Jagiellonian UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT03590171 | International Study for Treatment of High Risk Childhood Relapsed ALL 2010 | recruiting | Phase 2 | 250 | Charite University, Berlin, GermanyOTHER | 15 | Mar 17, 2026 | clinicaltrials |
| NCT03838926 | Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | recruiting | Phase 1 | 42 | Vanda PharmaceuticalsINDUSTRY | 2 | Mar 16, 2026 | clinicaltrials |
| NCT06768918 | Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries(AMBeR eRehab) | recruiting | N/A | 300 | Zealand University HospitalOTHER | 5 | Mar 12, 2026 | clinicaltrials |
| NCT05730036 | A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma(LINKER-MM3) | recruiting | Phase 3 | 410 | Regeneron PharmaceuticalsINDUSTRY | 18 | Mar 6, 2026 | clinicaltrials |
| NCT07088536 | Occupational Situation and Return to Work of Urological Patients(OCCURORTW) | recruiting | — | 2,000 | Jagiellonian UniversityOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | recruiting | Phase 4 | 787 | Eli Lilly and CompanyINDUSTRY | 8 | Mar 2, 2026 | clinicaltrials |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma | recruiting | Phase 4 | 279 | Eli Lilly and CompanyINDUSTRY | 8 | Mar 2, 2026 | clinicaltrials |
| NCT06532006 | A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer | recruiting | Phase 3 | 550 | Shanghai Henlius BiotechINDUSTRY | 17 | Feb 27, 2026 | clinicaltrials |
| NCT06809101 | Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.(AMBeR eBlood) | recruiting | — | 265 | Pomeranian Medical University SzczecinOTHER | 3 | Feb 27, 2026 | clinicaltrials |
| NCT05549297 | Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) | recruiting | Phase 3 | 540 | Immunocore LtdINDUSTRY | 12 | Feb 25, 2026 | clinicaltrials |
| NCT06112314 | IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)(PRISM-MEL-301) | recruiting | Phase 3 | 680 | Immunocore LtdINDUSTRY | 26 | Feb 25, 2026 | clinicaltrials |
| NCT04833894 | Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis(ADAPT Jr) | recruiting | Phase 2 / Phase 3 | 12 | argenxINDUSTRY | 12 | Feb 18, 2026 | clinicaltrials |
| NCT05879757 | Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency | recruiting | — | 75 | TakedaINDUSTRY | 11 | Feb 18, 2026 | clinicaltrials |
| NCT05544019 | Study of SGR-1505 in Mature B-Cell Neoplasms | recruiting | Phase 1 | 98 | Schrödinger, Inc.INDUSTRY | 8 | Feb 13, 2026 | clinicaltrials |
| NCT07397715 | Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms(MUSA3) | recruiting | — | 1,000 | Swiss GO Trial GroupNETWORK | 3 | Feb 12, 2026 | clinicaltrials |
| NCT07250750 | A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis(Synergy-MG) | recruiting | Phase 1 / Phase 2 | 96 | ImmunAbs Inc.INDUSTRY | 6 | Feb 11, 2026 | clinicaltrials |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer | recruiting | Phase 3 | 550 | Jazz PharmaceuticalsINDUSTRY | 15 | Feb 10, 2026 | clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT06908304 | A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC | recruiting | Phase 3 | 300 | Maia BiotechnologyINDUSTRY | 4 | Jan 12, 2026 | clinicaltrials |
| NCT02986516 | Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease(SACRO) | recruiting | N/A | 100 | Italian Sarcoma GroupNETWORK | 10 | Jan 2, 2026 | clinicaltrials |
| NCT06527027 | LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes | recruiting | N/A | 1,000 | Copernicus Memorial HospitalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07270263 | Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies(HEM-DOAC) | recruiting | N/A | 100 | Medical University of GdanskOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT06940947 | Endoscopic Therapy Or Surgery for Early Colon Cancer(ETHOS) | recruiting | Phase 3 | 434 | Norwegian Department of Health and Social AffairsOTHER_GOV | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06590961 | UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies | recruiting | Phase 1 | 94 | Ubix Therapeutics, Inc.INDUSTRY | 3 | Nov 19, 2025 | clinicaltrials |
| NCT07216157 | NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery(NoSeal) | recruiting | N/A | 225 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06529081 | Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer | recruiting | N/A | 165 | Copernicus Memorial HospitalOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT07120529 | Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.(MOOSE) | recruiting | — | 300 | Medical University of SilesiaOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT05738603 | The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery. | recruiting | N/A | 206 | Jakub SzramaOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06917963 | Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1(STOP-HOS-1) | recruiting | N/A | 80 | Medical University of GdanskOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06574087 | Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases. | recruiting | N/A | 248 | PCK Marine Hospital in GdyniaOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT06954233 | Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer(VEEF-RPLND-TC) | recruiting | — | 20 | Jagiellonian UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT04740424 | FS222 First in Human Study in Patients With Advanced Malignancies | recruiting | Phase 1 | 260 | invoX Pharma LimitedINDUSTRY | 7 | Jul 1, 2025 | clinicaltrials |
| NCT02285582 | International Rare Histiocytic Disorders Registry (IRHDR)(IRHDR) | recruiting | — | 400 | The Hospital for Sick ChildrenOTHER | 9 | Jun 24, 2025 | clinicaltrials |
| NCT05966675 | Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI(PACE-4-TAVI) | recruiting | N/A | 500 | Medical University of SilesiaOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT07011316 | Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH)(ONCOLYMPH) | recruiting | — | 600 | The Greater Poland Cancer CentreOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT07001085 | ctDNA Monitoring in Patients With HCC and mCRC | recruiting | N/A | 300 | Medical University of WarsawOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06975332 | Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression | recruiting | N/A | 35 | Medical University of WarsawOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT05582876 | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer(PROSPETMR2021) | recruiting | N/A | 366 | Medical University of BialystokOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT05715502 | Focal Salvage Brachytherapy Study (FocaSaBra)(FocaSaBra) | recruiting | N/A | 100 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT05201404 | Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis(LIVERATION) | recruiting | Phase 3 | 471 | Can-Fite BioPharmaINDUSTRY | 9 | Apr 29, 2025 | clinicaltrials |
| NCT03571568 | A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL | recruiting | Phase 1 / Phase 2 | 140 | BioInvent International ABINDUSTRY | 6 | Apr 24, 2025 | clinicaltrials |
| NCT04875611 | Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment(NIVONASO-21) | recruiting | Phase 2 | 32 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT04920968 | Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"(OVERALL) | recruiting | Phase 2 | 124 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06936969 | Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for Postoperative Air Leak After Lung Resections(GLUC-PAL) | recruiting | N/A | 200 | Wielkopolskie Centrum Pulmonologii i TorakochirurgiiOTHER | 1 | Apr 20, 2025 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials